Bioelectronic Medicine on the Rise

Bioelectronic medicine could be one of healthcare’s biggest secrets. The space is filled with applications – but many aren’t mainstream yet. A panel titled “ Bioelectronic Medicine: Redefining Medical Treatment,” will be held Tuesday, February 11, from 2:05 to 3:00 p.m. in Room 210A at MD&M West Anaheim to discuss the space and how it could impact healthcare. While there have been some significant movements in that time – perhaps one of the greatest has developments has been GlaxoSmithKline teaming up with Verily Lifesciences to form the Galvani Bioelectronics joint venture in 2016. This move helped to open up the floodgates for technologies coming out of the space. Recently there have been a number of companies and technologies stepping up to the plate. Neuro Sigma’s Monarch external Trigeminal Nerve Stimulation (eTNS) System made history in 2019 when it became the first device to win a nod from FDA to treat attention deficit hyperactivity disorder (ADHD). Monarch is about the size of a cellphone. The device generates a low-level electrical pulse and connects via a wire to a small patch that adheres to a patient's forehead, just above the eyebrows, and should feel like a tingling sensation on the skin. Fempulse made an impact in the bioelectronic medicine market with therapy for the personalized treatment of overactive bladder (OAB) in women. The ...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Electronics Source Type: news